Trademark: LYFAQUIN 2147519
Word
LYFAQUIN
ID
2147519
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
29 September 2020
Registration Date
29 September 2020
Renewal Date
29 September 2030
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.
Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.